PMC:7405836 / 89328-89528 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T833","span":{"begin":56,"end":64},"obj":"Disease"},{"id":"T834","span":{"begin":56,"end":60},"obj":"Disease"},{"id":"T835","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"T836","span":{"begin":71,"end":75},"obj":"Disease"},{"id":"T837","span":{"begin":161,"end":169},"obj":"Disease"},{"id":"T838","span":{"begin":161,"end":165},"obj":"Disease"},{"id":"T839","span":{"begin":189,"end":197},"obj":"Disease"},{"id":"T840","span":{"begin":189,"end":193},"obj":"Disease"}],"attributes":[{"id":"A833","pred":"mondo_id","subj":"T833","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A834","pred":"mondo_id","subj":"T834","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A835","pred":"mondo_id","subj":"T835","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A836","pred":"mondo_id","subj":"T836","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A837","pred":"mondo_id","subj":"T837","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A838","pred":"mondo_id","subj":"T838","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A839","pred":"mondo_id","subj":"T839","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A840","pred":"mondo_id","subj":"T840","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Hence, the superior genetic similarity existing between SARS-CoV-2 and SARS-CoV can be utilized to repurpose vaccines that have proven in vitro efficacy against SARS-CoV to be utilized for SARS-CoV-2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T622","span":{"begin":0,"end":200},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hence, the superior genetic similarity existing between SARS-CoV-2 and SARS-CoV can be utilized to repurpose vaccines that have proven in vitro efficacy against SARS-CoV to be utilized for SARS-CoV-2."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2477","span":{"begin":56,"end":66},"obj":"Species"},{"id":"2478","span":{"begin":71,"end":79},"obj":"Species"},{"id":"2479","span":{"begin":161,"end":169},"obj":"Species"},{"id":"2480","span":{"begin":189,"end":199},"obj":"Species"}],"attributes":[{"id":"A2477","pred":"tao:has_database_id","subj":"2477","obj":"Tax:2697049"},{"id":"A2478","pred":"tao:has_database_id","subj":"2478","obj":"Tax:694009"},{"id":"A2479","pred":"tao:has_database_id","subj":"2479","obj":"Tax:694009"},{"id":"A2480","pred":"tao:has_database_id","subj":"2480","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Hence, the superior genetic similarity existing between SARS-CoV-2 and SARS-CoV can be utilized to repurpose vaccines that have proven in vitro efficacy against SARS-CoV to be utilized for SARS-CoV-2."}